Peloton Therapeutics, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa)

This study is testing an oral drug called belzutifan for people with von Hippel-Lindau (VHL) disease who have kidney tumors. The goal is to see if continuous daily treatment can shrink these tumors and delay the need for surgery. The study will also monitor how the drug affects o…